Gregory J Morton1, Karl J Kaiyala, Karen E Foster-Schubert, David E Cummings, Michael W Schwartz. 1. Department of Medicine (G.J.M., K.E.F.-S., D.E.C., M.W.S.) and Department of Dental Public Health Sciences (K.J.K.), School of Dentistry, University of Washington, Seattle, Washington 98195; and Veterans Affairs Puget Sound Health Care System (K.E.F.-S., D.E.C.), Seattle, Washington 98108.
Abstract
CONTEXT: Fibroblast growth factor 19 (FGF19) improves glycemic control in diabetic animals and is secreted from the gastrointestinal tract after meals in response to bile acid stimulation. OBJECTIVE: We sought to understand how ingestion of carbohydrates, protein or lipids affect both FGF19 and bile acid concentrations in human plasma, with the hypothesis that variation in the bile acid response to different macronutrients would predict differences in plasma FGF19 levels. DESIGN: This was a randomized, within-subjects crossover study. SETTING: The study was conducted at a university clinical research center. PARTICIPANTS: There were 16 healthy human subjects included in the study. INTERVENTIONS:Isocaloric, isovolemic beverages composed primarily of carbohydrates, proteins, or lipids were provided to each participant on 3 separate occasions. MAIN OUTCOME MEASURES: The magnitudes of postprandial rises of plasma FGF19 and total bile acid levels were determined. RESULTS: All beverages induced an initial transient decline of plasma FGF19 levels during the first 60 minutes after consumption. For FGF19, the ingestion of carbohydrate was associated with the fastest and highest increase of plasma levels, returning to baseline at 5 hours. By comparison, the protein beverage induced a modest but significant elevation of FGF19 levels that peaked at the end of the 6-hour sampling interval, whereas a lipid beverage was without effect. In contrast, total bile acid levels increased in plasma only in response to a high-lipid beverage, demonstrating a marked divergence between the FGF19 and bile acid response to lipid vs carbohydrate. CONCLUSIONS: A bile acid-independent mechanism is implicated in the effect of meals to raise plasma FGF19 concentrations.
RCT Entities:
CONTEXT: Fibroblast growth factor 19 (FGF19) improves glycemic control in diabetic animals and is secreted from the gastrointestinal tract after meals in response to bile acid stimulation. OBJECTIVE: We sought to understand how ingestion of carbohydrates, protein or lipids affect both FGF19 and bile acid concentrations in human plasma, with the hypothesis that variation in the bile acid response to different macronutrients would predict differences in plasma FGF19 levels. DESIGN: This was a randomized, within-subjects crossover study. SETTING: The study was conducted at a university clinical research center. PARTICIPANTS: There were 16 healthy human subjects included in the study. INTERVENTIONS: Isocaloric, isovolemic beverages composed primarily of carbohydrates, proteins, or lipids were provided to each participant on 3 separate occasions. MAIN OUTCOME MEASURES: The magnitudes of postprandial rises of plasma FGF19 and total bile acid levels were determined. RESULTS: All beverages induced an initial transient decline of plasma FGF19 levels during the first 60 minutes after consumption. For FGF19, the ingestion of carbohydrate was associated with the fastest and highest increase of plasma levels, returning to baseline at 5 hours. By comparison, the protein beverage induced a modest but significant elevation of FGF19 levels that peaked at the end of the 6-hour sampling interval, whereas a lipid beverage was without effect. In contrast, total bile acid levels increased in plasma only in response to a high-lipid beverage, demonstrating a marked divergence between the FGF19 and bile acid response to lipid vs carbohydrate. CONCLUSIONS: A bile acid-independent mechanism is implicated in the effect of meals to raise plasma FGF19 concentrations.
Authors: Karen E Foster-Schubert; Joost Overduin; Catherine E Prudom; Jianhua Liu; Holly S Callahan; Bruce D Gaylinn; Michael O Thorner; David E Cummings Journal: J Clin Endocrinol Metab Date: 2008-01-15 Impact factor: 5.958
Authors: R E Roberts; C Glicksman; J Alaghband-Zadeh; R A Sherwood; N Akuji; C W le Roux Journal: Clin Endocrinol (Oxf) Date: 2011-01 Impact factor: 3.478
Authors: Matthew J Potthoff; Jamie Boney-Montoya; Mihwa Choi; Tianteng He; Nishanth E Sunny; Santhosh Satapati; Kelly Suino-Powell; H Eric Xu; Robert D Gerard; Brian N Finck; Shawn C Burgess; David J Mangelsdorf; Steven A Kliewer Journal: Cell Metab Date: 2011-06-08 Impact factor: 27.287
Authors: Serkan Kir; Sara A Beddow; Varman T Samuel; Paul Miller; Stephen F Previs; Kelly Suino-Powell; H Eric Xu; Gerald I Shulman; Steven A Kliewer; David J Mangelsdorf Journal: Science Date: 2011-03-25 Impact factor: 47.728
Authors: Zhao Shan; Gloria Alvarez-Sola; Iker Uriarte; María Arechederra; Maite G Fernández-Barrena; Carmen Berasain; Cynthia Ju; Matías A Avila Journal: Ann Transl Med Date: 2018-06
Authors: Lydia-Ann L S Harris; Gordon I Smith; Bettina Mittendorfer; J Christopher Eagon; Adewole L Okunade; Bruce W Patterson; Samuel Klein Journal: J Clin Endocrinol Metab Date: 2017-10-01 Impact factor: 5.958
Authors: Arno R Bourgonje; Laura A Bolte; Lianne L C Vranckx; Lieke M Spekhorst; Ranko Gacesa; Shixian Hu; Hendrik M van Dullemen; Marijn C Visschedijk; Eleonora A M Festen; Janneke N Samsom; Gerard Dijkstra; Rinse K Weersma; Marjo J E Campmans-Kuijpers Journal: Nutrients Date: 2022-06-17 Impact factor: 6.706
Authors: J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya Journal: Int J Obes (Lond) Date: 2014-05-12 Impact factor: 5.095
Authors: Bigina N R Ginos; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Dongfang Wang; Timothy W Randolph; Ali Shojaie; Meredith A J Hullar; Paul D Lampe; Mario Kratz; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe Journal: Metabolism Date: 2018-02-17 Impact factor: 8.694